78
Views
4
CrossRef citations to date
0
Altmetric
Original

A Tailored Target Intervention on Influence Factors of Quality of Life in Chinese Patients with Hypertension

, , , , , , , , & show all
Pages 71-82 | Received 24 Mar 2008, Accepted 30 May 2008, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bi-Lian Chen, Yin-Zhuang Zhang, Jian-Quan Luo & Wei Zhang. (2015) Clinical use of azelnidipine in the treatment of hypertension in Chinese patients. Therapeutics and Clinical Risk Management 11, pages 309-318.
Read now

Articles from other publishers (3)

Thi-Phuong-Lan Nguyen, Paul F. M. Krabbe, Thi-Bach-Yen Nguyen, Catharina C. M. Schuiling-Veninga, E. Pamela Wright & Maarten J. Postma. (2015) Utilities of Patients with Hypertension in Northern Vietnam. PLOS ONE 10:10, pages e0139560.
Crossref
Jia-Meng Ma, Ai Shibata & Isao Muraoka. (2011) Relationship between meeting the recommendations for physical activity and health-related quality of life in adult Chinese Internet users. Open Journal of Preventive Medicine 01:03, pages 94-100.
Crossref
Deborah Rohm Young, Janelle Coughlin, Gerald J. Jerome, Valerie Myers, Soo Eun Chae & Phillip J. Brantley. (2010) Effects of the PREMIER Interventions on Health-Related Quality of Life. Annals of Behavioral Medicine 40:3, pages 302-312.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.